CIBC Private Wealth Group
INSY

CIBC Private Wealth Group’s Insys Therapeutics, Inc. INSY Stock Holding History

CIBC Private Wealth Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-24
Closed – – 1935
2018
Q2 		$0 Hold
24
– – ﹤0.01% 2160
2018
Q1 		$0 Sell
24
-2,000
-99% -$16.5K ﹤0.01% 2146
2017
Q4 		$19K Buy
+2,024
New +$13.2K ﹤0.01% 1420

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIBC Private Wealth Group's INSY Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Insys Therapeutics, Inc. (INSY) in Q3 2018, closing a stake of 24 shares.

CIBC Private Wealth Group first reported a position in INSY in Q4 2017 and held it in 3 quarters. The position peaked at $19K in Q4 2017. 110 funds tracked by Wall St. Rank hold INSY as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Insys Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 24 Insys Therapeutics, Inc. shares in Q3 2018.
  • CIBC Private Wealth Group first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Insys Therapeutics, Inc. position peaked at $19K in Q4 2017.
  • 110 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.